Literature DB >> 21995934

Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors.

Laura G Wesolowski1, Kevin P Delaney, Clyde Hart, Carolyn Dawson, S Michele Owen, Debra Candal, William A Meyer, Steven F Ethridge, Bernard M Branson.   

Abstract

BACKGROUND: The HIV-1 Western blot (WB) and immunofluorescence assay used to confirm HIV infections are less sensitive during seroconversion than immunoassays (IAs) used for screening. An alternative diagnostic algorithm has been proposed to detect early HIV-1 infection and differentiate HIV-1 from HIV-2.
OBJECTIVES: We evaluated the performance of an algorithm with a third generation IA that when reactive was followed by a rapid test (Multispot) that differentiates HIV-1 from HIV-2. Multispot-reactive specimens were considered HIV-infected. Multispot-negative specimens were tested with a nucleic acid amplification test (NAAT) for resolution. STUDY
DESIGN: WB-positive specimens [serum (n=2202), plasma (n=1109) and peripheral blood mononuclear cells (PBMCs) (n=1065)] were obtained from HIV-infected persons not taking antiretrovirals. HIV-uninfected specimens [plasma (n=1517) and PBMCs (n=1508)] with negative IA and NAAT results were obtained from blood donors. Specimens were tested with third generation IAs (Abbott rDNA, ADVIA Centaur, GS HIV1-2 Plus O, Ortho VITROS) in singlet, Multispot, and NAAT (APTIMA (RNA) and AMPLICOR (DNA)). We calculated algorithm sensitivity and specificity and the proportion of IA-reactive specimens requiring NAAT.
RESULTS: Algorithm sensitivity was 99.95% with APTIMA and 100% with AMPLICOR. One WB-positive specimen reactive by all IAs and AMPLICOR was negative by Multispot and APTIMA. Algorithm specificity was 100% using APTIMA or AMPLICOR as NAAT. From 0.10% (Abbott) to 2.43% (VITROS) of IA-reactive specimens required NAAT.
CONCLUSIONS: The proposed algorithm performs with high sensitivity and specificity in specimens from persons with established HIV infection and uninfected blood donors and appears to be a good alternative to the current algorithm. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21995934     DOI: 10.1016/j.jcv.2011.09.026

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  8 in total

1.  Infectious disease/CDC update. Detection of acute HIV infection in two evaluations of a new HIV diagnostic testing algorithm--United States, 2011-2013.

Authors:  Richard E Rothman; Mustapha Saheed; Yu-Hsiang Hsieh
Journal:  Ann Emerg Med       Date:  2014-01       Impact factor: 5.721

2.  Prevalence of HIV Indeterminate Western Blot Tests and Follow-up of HIV Antibody Sero-Conversion in Southeastern China.

Authors:  Shouli Wu; Min Gao; Jian Zheng; Pingping Yan; Wei Wang; Xiaoli Lu; Yuefeng Qiu; Yansheng Yan
Journal:  Virol Sin       Date:  2019-06-12       Impact factor: 4.327

3.  Use of rapid HIV assays as supplemental tests in specimens with repeatedly reactive screening immunoassay results not confirmed by HIV-1 Western blot.

Authors:  Laura G Wesolowski; Kevin P Delaney; William A Meyer; Amy J Blatt; Berry Bennett; Pollyanna Chavez; Timothy C Granade; Michele Owen
Journal:  J Clin Virol       Date:  2013-07-06       Impact factor: 3.168

4.  Acute infections, cost and time to reporting of HIV test results in three U.S. State Public Health Laboratories.

Authors:  Muazzam Nasrullah; Laura G Wesolowski; Steven F Ethridge; Kevin Cranston; Michael Pentella; Robert A Myers; James T Rudrik; Angela B Hutchinson; Spencer B Bennett; Barbara G Werner
Journal:  J Infect       Date:  2016-05-26       Impact factor: 6.072

5.  Performance evaluation of the Aptima HIV-1 RNA Quant assay on the Panther system using the standard and dilution protocols.

Authors:  Rebecca Rossetti; Tara Smith; Wei Luo; Jennifer Taussig; Mariah Valentine-Graves; Patrick Sullivan; Jessica M Ingersoll; Colleen S Kraft; Steve Ethridge; Laura Wesolowski; Kevin P Delaney; S Michele Owen; Jeffrey A Johnson; Silvina Masciotra
Journal:  J Clin Virol       Date:  2020-06-01       Impact factor: 3.168

6.  Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm.

Authors:  Muazzam Nasrullah; Laura G Wesolowski; William A Meyer; S Michele Owen; Silvina Masciotra; Craig Vorwald; William J Becker; Bernard M Branson
Journal:  AIDS       Date:  2013-03-13       Impact factor: 4.177

7.  Comparative performance of electrochemiluminescence immunoassay and EIA for HIV screening in a multiethnic region of China.

Authors:  Xiaohui Bi; Hongxia Ning; Tingting Wang; Dongdong Li; Yongming Liu; Tingfu Yang; Jiansheng Yu; Chuanmin Tao
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

8.  Evaluation of Blood-Based Antibody Rapid Testing for HIV Early Therapy: A Meta-Analysis of the Evidence.

Authors:  Xiaojie Huang; Xinchao Liu; Jieqing Chen; Yugang Bao; Jianhua Hou; Xiaofan Lu; Wei Xia; Huan Xia; Aixin Song; Zhiying Liu; Bin Su; Hui Chen; Yaokai Chen; Hao Wu
Journal:  Front Immunol       Date:  2018-06-26       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.